(“Cyprotex” or the “Company”)
Rule 2.10 Announcement
Pursuant to Rule 2.10 of the City Code on Mergers and Acquisitions (the "Code"), Cyprotex confirms that it has 178,957,188 ordinary shares of 0.1p each ("Ordinary Shares"), in issue and admitted to trading on the AIM market of the London Stock Exchange. The International Securities Identification Number for the ordinary shares is GB0031214470.
Rule 19.11 disclosure
In accordance with Rule 19.11 of the Code, a copy of this Announcement will be published on the Cyprotex website: www.cyprotex.com.
Execution Noble & Company Limited
John Llewellyn-Lloyd / Sam Reynolds
020 7456 9191
Ben Brewerton / Ben Atwell / John Dineen
020 7831 3113